TERANCE CHI: Open Payments
NPI 1225367402 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 48 payments from 16 companies in 2025. Trend: 2023 $59 · 2024 $479 · 2025 $1,287
Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $297 |
| AstraZeneca Pharmaceuticals LP | 9 | $241 |
| Kowa Pharmaceuticals America, Inc. | 8 | $179 |
| Amgen Inc. | 1 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $79 |
| Novo Nordisk Inc | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Esperion Therapeutics, Inc. | 2 | $47 |
| Madrigal Pharmaceuticals | 2 | $42 |
| Exact Sciences Corporation | 1 | $28 |
Products named: Kerendia, ZORYVE, AIRSUPRA, REPATHA, JARDIANCE, LEQVIO, FARXIGA, NEXLETOL.
Industry payments across WI — which companies pay providers there.
